NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.
View Top Employees from NeoTX Therapeutics LTDWebsite | http://www.neotx.com/ |
Revenue | $5.1 million |
Employees | 31 (31 on RocketReach) |
Founded | 2015 |
Address | 2 Pekeris St, Rehovot, Central District 7670202, IL |
Phone | (609) 718-2305 |
Fax | +972 8-936-8584 |
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Health Diagnostics, Health Care, Medical, Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies |
Looking for a particular NeoTX Therapeutics LTD employee's phone or email?
The NeoTX Therapeutics LTD annual revenue was $5.1 million in 2024.
Marcel Rozencweig is the President of NeoTX Therapeutics LTD.
31 people are employed at NeoTX Therapeutics LTD.
NeoTX Therapeutics LTD is based in Rehovot, Central District.
The NAICS codes for NeoTX Therapeutics LTD are [325, 3254, 54, 32, 32541, 541].
The SIC codes for NeoTX Therapeutics LTD are [283, 28].